Margaret A. Ponder

5.6k total citations · 1 hit paper
25 papers, 4.2k citations indexed

About

Margaret A. Ponder is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Margaret A. Ponder has authored 25 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Neurology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Margaret A. Ponder's work include Neurofibromatosis and Schwannoma Cases (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Margaret A. Ponder is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (9 papers), Neuroendocrine Tumor Research Advances (7 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Margaret A. Ponder collaborates with scholars based in United Kingdom, United States and Germany. Margaret A. Ponder's co-authors include Lois M. Mulligan, Catherine S. Healey, Charis Eng, Emily Gardner, John B. Kwok, Bruce A.J. Ponder, Bruce A.J. Ponder, Douglas F. Easton, Alan Tunnacliffe and Laura Papi and has published in prestigious journals such as Nature, Nature Genetics and Human Molecular Genetics.

In The Last Decade

Margaret A. Ponder

25 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

1993 1.4k citations Lois M. Mulligan, John B. Kwok et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret A. Ponder United Kingdom	22	1.7k	1.3k	1.2k	1.2k	1.0k	25	4.2k
Laura Papi Italy	25	791 0.5×	1.2k 0.9×	892 0.7×	859 0.7×	766 0.8×	68	3.2k
Emily Gardner United Kingdom	14	1.3k 0.8×	1.0k 0.8×	794 0.7×	360 0.3×	812 0.8×	30	2.8k
Anne Barlier France	38	2.4k 1.4×	1.1k 0.8×	1.2k 1.0×	726 0.6×	469 0.5×	165	4.4k
Rudy M. Landsvater Netherlands	12	778 0.5×	780 0.6×	499 0.4×	218 0.2×	574 0.6×	15	1.9k
Koji Toshima Japan	9	1.2k 0.7×	631 0.5×	616 0.5×	227 0.2×	517 0.5×	13	2.0k
Martin Bäckdahl Sweden	34	1.4k 0.8×	845 0.6×	255 0.2×	209 0.2×	612 0.6×	73	3.1k
Gérald Raverot France	43	4.3k 2.6×	1.0k 0.8×	1.5k 1.3×	478 0.4×	273 0.3×	181	5.6k
Irina A. Lubensky United States	34	242 0.1×	1.6k 1.2×	1.2k 1.0×	890 0.7×	1.3k 1.3×	65	3.8k
Katrin M. Carlson United States	10	813 0.5×	716 0.5×	541 0.4×	244 0.2×	497 0.5×	13	1.9k
David G. McFadden United States	21	1.1k 0.7×	2.0k 1.5×	364 0.3×	171 0.1×	582 0.6×	36	3.6k

Countries citing papers authored by Margaret A. Ponder

Since Specialization

Citations

This map shows the geographic impact of Margaret A. Ponder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret A. Ponder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret A. Ponder more than expected).

Fields of papers citing papers by Margaret A. Ponder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret A. Ponder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret A. Ponder. The network helps show where Margaret A. Ponder may publish in the future.

Co-authorship network of co-authors of Margaret A. Ponder

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret A. Ponder. A scholar is included among the top collaborators of Margaret A. Ponder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret A. Ponder. Margaret A. Ponder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walker, Lyndon, Deborah J. Thompson, Douglas F. Easton, et al.. (2006). A prospective study of neurofibromatosis type 1 cancer incidence in the UK. British Journal of Cancer. 95(2). 233–238. 156 indexed citations

Upadhyaya, Meena, Martino Ruggieri, Julie Maynard, et al.. (1998). Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Human Genetics. 102(5). 591–597. 117 indexed citations

Upadhyaya, Meena, Julie Maynard, M. Osborn, et al.. (1995). Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.. Journal of Medical Genetics. 32(9). 706–710. 35 indexed citations

Eng, Charis, Dean P. Smith, Lois M. Mulligan, et al.. (1995). A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.. PubMed. 10(3). 509–13. 209 indexed citations

Eng, Charis, Darrin P. Smith, Catherine S. Healey, et al.. (1995). Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clinical Endocrinology. 43(1). 123–127. 121 indexed citations

Eng, Charis, Lois M. Mulligan, Darrin P. Smith, et al.. (1995). Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes and Cancer. 12(3). 209–212. 123 indexed citations

McMahon, Robert, Lois M. Mulligan, Catherine S. Healey, et al.. (1994). Direct, non-radioactive detection of mutations in Multiple Endocrine Neoplasia Type 2A families. Human Molecular Genetics. 3(4). 643–646. 35 indexed citations

Mulligan, Lois M., Charis Eng, Catherine S. Healey, et al.. (1994). A de novo mutation of the RET proto-oncogene in a patient with MEN 2A. Human Molecular Genetics. 3(6). 1007–1008. 23 indexed citations

Eng, Charis, Darrin P. Smith, Lois M. Mulligan, et al.. (1994). Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Human Molecular Genetics. 3(2). 237–241. 394 indexed citations

10.

Mulligan, Lois M., Charis Eng, Catherine S. Healey, et al.. (1994). Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics. 6(1). 70–74. 495 indexed citations

11.

Gardner, Emily, Lois M. Mulligan, Charis Eng, et al.. (1994). Haplotype analysis of MEN 2 mutations. Human Molecular Genetics. 3(10). 1771–1774. 19 indexed citations

12.

Steichen‐Gersdorf, Elisabeth, Holly H. Gallion, D.F. Easton, et al.. (1994). Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.. PubMed. 55(5). 870–5. 68 indexed citations

13.

Mulligan, Lois M., John B. Kwok, Catherine S. Healey, et al.. (1993). Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363(6428). 458–460. 1446 indexed citations breakdown →

14.

Gardner, Emily, Laura Papi, Douglas F. Easton, et al.. (1993). Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Human Molecular Genetics. 2(3). 241–246. 76 indexed citations

15.

Xu, Weiming, et al.. (1992). Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes and Cancer. 4(4). 337–342. 122 indexed citations

16.

Xu, Weiming, et al.. (1992). Molecular analysis of neurofibromatosis type 1 mutations. Human Mutation. 1(6). 474–477. 6 indexed citations

17.

Maher, Eamonn R., Elizabeth Bentley, John R.W. Yates, et al.. (1990). Mapping of Von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. Journal of the Neurological Sciences. 100(1-2). 27–30. 33 indexed citations

18.

Jadayel, D, Pamela R. Fain, Meena Upadhyaya, et al.. (1990). Paternal origin of new mutations in Von Recklinghausen neurofibromatosis. Nature. 343(6258). 558–559. 154 indexed citations

19.

Thorpe, Karen L., et al.. (1989). Linkage analysis of chromosome 17 markers in British and South African families with neurofibromatosis type I.. PubMed. 44(1). 38–40. 12 indexed citations

20.

Ponder, Bruce A.J., Nick Finer, Rebecca Coffey, et al.. (1988). Family Screening in Medullary Thyroid Carcinoma Presenting Without a Family History. QJM. 67(252). 299–308. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact